Donate Help Contact The AHA Sign In Home
American Heart Association
Arteriosclerosis, Thrombosis, and Vascular Biology
Search: search_blue_button Advanced Search
Arteriosclerosis, Thrombosis, and Vascular Biology. 2006;26:379-384
Published online before print November 23, 2005, doi: 10.1161/01.ATV.0000197844.06411.22
This Article
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow Data Supplement
Right arrow All Versions of this Article:
26/2/379    most recent
01.ATV.0000197844.06411.22v1
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow Request Permissions
Citing Articles
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by van der Harst, P.
Right arrow Articles by van Gilst, W. H.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by van der Harst, P.
Right arrow Articles by van Gilst, W. H.
Right arrowPubmed/NCBI databases
*Compound via MeSH
*Substance via MeSH
Medline Plus Health Information
*Coronary Artery Disease
(Arteriosclerosis, Thrombosis, and Vascular Biology. 2006;26:379.)
© 2006 American Heart Association, Inc.


Atherosclerosis and Lipoproteins

Vascular Function and Mild Renal Impairment in Stable Coronary Artery Disease

Pim van der Harst; Tom D.J. Smilde; Hendrik Buikema; Adriaan A. Voors; Gerjan Navis; Dirk J. van Veldhuisen; Wiek H. van Gilst

From the Departments of Cardiology (P.v.d.H., T.D.J.S., A.A.V., D.J.v.V.), Clinical Pharmacology (P.v.d.H., H.B., W.H.v.G.), and Internal Medicine Division of Nephrology (G.N.), University Medical Center Groningen, University of Groningen, The Netherlands.

Correspondence to P. van der Harst, Department of Cardiology, Thoraxcenter, University Medical Center Groningen, Hanzeplein 1, PO Box 30001, 9700 RB Groningen, The Netherlands. E-mail p.van.der.harst{at}thorax.umcg.nl

Objective— In patients with coronary artery disease, the concomitant presence of renal function impairment is associated with decreased survival. We aimed to assess whether in coronary artery diseased patients renal function impairment is associated with systemic vascular function, functional parameters of the renin-angiotensin system, or inflammation as potential mediators for cardiovascular risk.

Methods and Results— We studied 125 patients, 87% male, with a mean age of 62.2±8.2 years; 72% had 3-vessel disease, and mean renal function was 74±13 mL/min per 1.73 m2. Internal thoracic artery rings were sampled during coronary bypass surgery and used for in vitro vascular measurements. We could not establish an association between endothelium-dependent vasorelaxation (response to methacholine) and renal function. In addition, vascular response to potassium chloride, phenylephrine, and angiotensin II were not associated with renal function. Finally, serum angiotensin-converting enzyme (ACE) activity, usage of ACE inhibitors, C-reactive protein, and soluble intercellular adhesion molecule 1 were not related to renal function.

Conclusions— In coronary artery disease patients, mild renal function impairment is not associated with systemic vasomotor responsiveness, inflammation, or functional systemic parameters of the renin-angiotensin system. The relation between systemic endothelial dysfunction and mild renal insufficiency might be more complicated than previously thought.


Key Words: vascular function • coronary artery disease • endothelium • renal function angiotensin II